Andjela Kusic‐Pajic

Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial

Nazzareno Galiè, LJ Rubin, Pavel Jansa et al. · The Lancet · 2008 · 913 citations

Hypertension, Pulmonary Arterial Hypertension, Cardiovascular Disease +9

Pharmacokinetic and clinical profile of a novel formulation of bosentan in children with pulmonary arterial hypertension: the FUTURE‐1 study

Maurice Beghetti, Sheila G. Haworth, Damien Bonnet et al. · British Journal of Clinical Pharmacology · 2009 · 116 citations · Full text

Bosentan as Adjunctive Therapy for Persistent Pulmonary Hypertension of the Newborn: Results of the Randomized Multicenter Placebo-Controlled Exploratory Trial

Robin H. Steinhorn, Jeffrey R. Fineman, Andjela Kusic‐Pajic et al. · The Journal of Pediatrics · 2016 · 97 citations

Hypertension, Adjunctive Therapy, Neonatology +12

Long-term results from the EARLY study of bosentan in WHO functional class II pulmonary arterial hypertension patients

Gérald Simonneau, Nazzareno Galiè, Pavel Jansa et al. · International Journal of Cardiology · 2014 · 57 citations · Full text

FUTURE-2: Results from an open-label, long-term safety and tolerability extension study using the pediatric FormUlation of bosenTan in pUlmonary arterial hypeRtEnsion

Rolf M.F. Berger, Sheila G. Haworth, Damien Bonnet et al. · International Journal of Cardiology · 2015 · 44 citations

Hypertension, Pulmonary Arterial Hypertension, Pulmonary Circulation +10